143 related articles for article (PubMed ID: 30909848)
1. Role of routine blood tests for predicting clinical outcomes in osteosarcoma patients.
Jettoo P; Tan G; Gerrand CH; Rankin KS
J Orthop Surg (Hong Kong); 2019; 27(2):2309499019838293. PubMed ID: 30909848
[TBL] [Abstract][Full Text] [Related]
2. Pre-operative serum C-reactive protein as independent prognostic factor for survival but not infection in patients with high-grade osteosarcoma.
Funovics PT; Edelhauser G; Funovics MA; Laux C; Berzaczy D; Kubista B; Kotz RI; Dominkus M
Int Orthop; 2011 Oct; 35(10):1529-36. PubMed ID: 21249357
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
[TBL] [Abstract][Full Text] [Related]
4. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
Lin L; Deng S; Zhang F; Liang Y; Huang Z
World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the doubling time of serum C-reactive protein and alkaline phosphatase levels in primary bone and soft tissue tumors.
Yudoh K; Matsui H; Kamanori M; Ohmori K; Yasuda T; Tsuji H; Tatezaki S
Jpn J Cancer Res; 1996 Dec; 87(12):1288-95. PubMed ID: 9045965
[TBL] [Abstract][Full Text] [Related]
6. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
Han J; Yong B; Luo C; Tan P; Peng T; Shen J
World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of pre-treatment Naples prognostic score (NPS) in patients with osteosarcoma.
Yang Q; Chen T; Yao Z; Zhang X
World J Surg Oncol; 2020 Jan; 18(1):24. PubMed ID: 32000789
[TBL] [Abstract][Full Text] [Related]
8. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma.
Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH
Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506
[TBL] [Abstract][Full Text] [Related]
9. Correlation between prognostic factors and blood variables in osteosarcoma.
Broström LA; Ingimarsson S; Strander H; Eklund G
Acta Med Scand; 1980; 207(5):429-31. PubMed ID: 6930152
[TBL] [Abstract][Full Text] [Related]
10. [Multivariate analysis for prognostic factors among 43 patients with osteosarcoma].
Zhang B; Pang QJ; Zhang HJ; Yuan Y
Zhongguo Gu Shang; 2011 Dec; 24(12):982-6. PubMed ID: 22276503
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma.
Strojnik T; Smigoc T; Lah TT
Anticancer Res; 2014 Jan; 34(1):339-47. PubMed ID: 24403485
[TBL] [Abstract][Full Text] [Related]
12. Serum C-reactive protein and overall survival of patients with osteosarcoma.
Li X; Tian F; Wang F; Li Y
Tumour Biol; 2015 Jul; 36(7):5663-6. PubMed ID: 25986475
[TBL] [Abstract][Full Text] [Related]
13. Osteosarcoma in preadolescent patients: experience in a single institute in Taiwan.
Hsieh MY; Hung GY; Yen HJ; Chen WM; Chen TH
J Chin Med Assoc; 2009 Sep; 72(9):455-61. PubMed ID: 19762312
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.
Parikh M; Miller NR; Lee AG; Savino PJ; Vacarezza MN; Cornblath W; Eggenberger E; Antonio-Santos A; Golnik K; Kardon R; Wall M
Ophthalmology; 2006 Oct; 113(10):1842-5. PubMed ID: 16884778
[TBL] [Abstract][Full Text] [Related]
15. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone.
Nakamura T; Grimer RJ; Gaston CL; Watanuki M; Sudo A; Jeys L
Bone Joint J; 2013 Mar; 95-B(3):411-8. PubMed ID: 23450030
[TBL] [Abstract][Full Text] [Related]
17. The level of vascular endothelial growth factor as a predictor of a poor prognosis in osteosarcoma.
Kaya M; Wada T; Nagoya S; Sasaki M; Matsumura T; Yamashita T
J Bone Joint Surg Br; 2009 Jun; 91(6):784-8. PubMed ID: 19483233
[TBL] [Abstract][Full Text] [Related]
18. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.
Choi ES; Kim HS; Han I
Ann Surg Oncol; 2014 Mar; 21(3):778-85. PubMed ID: 24306668
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features and prognosis of osteosarcoma in Turkish adults.
Seker MM; Seker A; Aksoy S; Ozdemir N; Uncu D; Zengin N
Asian Pac J Cancer Prev; 2014; 15(8):3537-40. PubMed ID: 24870753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]